+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation

Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation

Diabetes Management 2(5s): 3-11

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 064171170

Download citation: RISBibTeXText

DOI: 10.2217/dmt.12.29

Related references

Bioequivalence evaluation of orally disintegrating tablet of pentoxyverine citrate. Nan Fang Yi Ke Da Xue Xue Bao 30(7): 1621-1623, 2010

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet. International Journal of Preventive Medicine 7: 120, 2016

Formulation and evaluation of a novel matrix-type orally disintegrating Ibuprofen tablet. Iranian Journal of Pharmaceutical Research 10(3): 469-479, 2011

Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation. European Journal of Pharmaceutics and Biopharmaceutics 85(3 Pt B): 1300-1309, 2013

Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug. Pharmaceutical Development and Technology 20(1): 60-64, 2015

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics. Drug Development and Industrial Pharmacy 40(7): 910-918, 2014

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. Clinical Oncology ) 11(5): 340-347, 1999

Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. International Journal of Pharmaceutics 400(1-2): 49-58, 2010

Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product. Pharmaceutical Development and Technology 22(2): 168-172, 2017

Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers. International Journal of Pharmaceutics 366(1-2): 149-153, 2009

Evaluation of Antihypertensive Efficacy and Patient Adherence to Treatment With the New Formulation Perindopril Arginine (Orally Disintegrating Tablet) in General Clinical Practice: OPTIMUM Program. Kardiologiia 56(4): 36-41, 2016

Bioequivalence assessment of ambroxol orally-disintegrating tablet after a single oral-dose administration to healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics 54(5): 399-404, 2016

Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet. Iranian Journal of Pharmaceutical Research 15(4): 677-686, 2016

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole. Therapeutic Advances in Gastroenterology 9(6): 759-769, 2016

Formulation study for orally disintegrating tablet using partly pregelatinized starch binder. Chemical and Pharmaceutical Bulletin 59(8): 959-964, 2011